Zinc Acetate Dihydrate
Epilepsy
Children's University Hospital Cologne, GermanyUNKNOWNPhase 2Active
CCC
54/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 73/ 100
Competitive context
64 Active assets in the Epilepsy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Lamotrigine Assiut University | Phase 4 | BBB |
Eslicarbazepine Acetate Bial - Portela C S.A. | Phase 4 | BBB |
Lacosamide Second Affiliated Hospital of Guangzhou Medical University | Phase 4 | BBB |
Neurotop Assistance Publique - Hôpitaux de Paris | Phase 4 | BBB |
Levetiracetam Beijing Tiantan Hospital | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
Zinc Acetate Dihydrate is also rated in:
global developmental delay with or without impaired intellectual developmentActive
B
Indicative · Phase 2
57 / 100
View asset →neurodevelopmental disorder with involuntary movementsActive
NR
Indicative · Phase 2
/ 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →